Browse the detailed record of transactions filed by 강일모, Chairman & CEO. Insider active across 2 companies, notably 케이엠제약. Aggregated, 9 filings have been published. The latest transaction was disclosed on 21 April 2026 — Purchase. Regulator: DART (FSS). All data is accessible without signup.
Kang Il-mo is the Chairman & CEO of KM Pharmaceuticals, a pharmaceutical company. He leads the company's efforts to develop new medications and improve existing treatments while ensuring regulatory compliance and product quality.